publicações selecionadas
-
artigo académico
- Unveiling the RKIP and EGFR Inverse Relationship in Solid Tumors: A Case Study in Cervical Cancer. Cancers. 2024
- Raf kinase inhibitor protein expression in smooth muscle tumours of the uterus: a diagnostic marker for leiomyosarcoma?. Reproductive BioMedicine Online. 2024
- Biological and therapeutic implications of RKIP in Gastrointestinal Stromal Tumor (GIST): an integrated transcriptomic and proteomic analysis. Cancer Cell International. 2023
- Sustainable fluorescent dye-faujasite zeolite systems as tools for cancer bioimaging 2023
- Targeting BUB3 in combination with paclitaxel inhibits proliferation of glioblastoma cells by enhancing cellular senescence. Scientific Letters. 2022
- Depletion of peripheral serotonin synthesis Induces benign prostatic growth in mice: more evidences for the new " Neuroendocrine theory" In BPH etiology . Journal of Urology. 2017
- MP31-16 SEROTONIN INHIBITS PROSTATE GROWTH DOWN REGULATING ANDROGEN RECEPTORS: EVIDENCE FOR A NOVEL THEORY FOR BPH. Journal of Urology. 2015
- Silencing of WNK2 is associated with upregulation of MMP2 and JNK in gliomas. Oncotarget. 2015
- Analysis of a synchronous gliosarcoma and meningioma with long survival: A case report and review of the literature. Surgical Neurology International. 2013
- In Vitro and In Vivo Analysis of RTK Inhibitor Efficacy and Identification of Its Novel Targets in Glioblastomas.. Translational Oncology. 2013
- Lymphangiogenic VEGF-C and VEGFR-3 expression in genetically characterised gastrointestinal stromal tumours. Histology and Histopathology. 2011
- Liquid-Based Cytology in DNA-Based Molecular Research Viability and Potential Application. Analytical and Quantitative Cytology and Histology. 2009
- Molecular alterations of KIT oncogene in gliomas. Cellular Oncology. 2007
-
artigo de conferência
- Evaluation of prostate cancer biosensor using Raman spectroscopy for remote monitoring applications 2024
- Hydrogel surface enhanced Raman spectroscopy sensor for monitoring prostate cancer 2024
- Omics profile of two immortalized Brazilian glioblastoma cell cultures. 2018
- AKT can modulate the in vitro response of HNSCC cell to irreversible EGFR inhibitors 2017
- HER receptors are Important theranostic biomarkers on cervical cancer: Blocking glucose metabolism enhances the therapeutic effect on HER Inhibitors 2016
- RKIP downregulation associates with poor prognosis in bladder cancer patients 2013
- TERT promoter mutation characterization in acral lentiginous melanomas 2013
- Protein Kinase WNK2 Was Correlated With Poor Outcome and Malignant Behavior in Glioma Cell Lines 2012
- Protein Kinase WNK2 has a Tumour Suppressor Role in Gliomas 2012
- Role of Glioblastoma Cell Metabolism in Response to Anti-RTK Therapy 2012
- Protein kinase WNK2 regulates cell migration in malignant gliomas 2011
- ASPM is an oncoprotein and activates EGFR 2010
- Analysis of raf kinase inhibitor protein (RKIP) expression as a prognostic marker for glioblastomas 2010
- Molecular Alterations of PDGFA and PDGFRA in Gliomas 2009
- A syncronous meningioma and gliosarcoma with long survival 2008
- Absence of KIT gene mutations and amplification in medulloblastomas 2008
- Analysis of MAP kinase signalling pathway in KIT & PDGFRA wild-type GISTs 2008
-
artigo de revista
- Cerebral Malaria Model Applying Human Brain Organoids. Cells. 2023
- Comprehensive Molecular Landscape of Cetuximab Resistance in Head and Neck Cancer Cell Lines. Cells. 2022
- Increased CD3+, CD8+, or FoxP3+ T Lymphocyte Infiltrations Are Associated with the Pathogenesis of Colorectal Cancer but Not with the Overall Survival of Patients. Biology. 2021
- A 30-Year Long-Term Experience in Appendix Neuroendocrine Neoplasms—Granting a Positive Outcome. Cancers. 2020
- WNK2 Inhibits Autophagic Flux in Human Glioblastoma Cell Line. Cells. 2020
- WNK2 Inhibits Autophagic Flux in Human Glioblastoma Cell Line. Cells. 2020
- RKIP as an Inflammatory and Immune System Modulator: Implications in Cancer. Biomolecules. 2019
- Semi-Synthetic Ingenol Derivative from Euphorbia tirucalli Inhibits Protein Kinase C Isotypes and Promotes Autophagy and S-phase Arrest on Glioma Cell Lines. Biomolecules. 2019
- Semi-Synthetic Ingenol Derivative from Euphorbia tirucalli Inhibits Protein Kinase C Isotypes and Promotes Autophagy and S-phase Arrest on Glioma Cell Lines. Biomolecules. 2019
- Modified ingenol semi-synthetic derivatives from Euphorbia tirucalli induce cytotoxicity on a large panel of human cancer cell lines. Investigational New Drugs. 2019
- Magnetoliposomes Containing Calcium Ferrite Nanoparticles for Applications in Breast Cancer Therapy. Pharmaceutics. 2019
- Hexane partition from Annona crassiflora Mart. promotes cytotoxity and apoptosis on human cervical cancer cell lines. Investigational New Drugs. 2019
- Current Status of Raf Kinase Inhibitor Protein (RKIP) in Lung Cancer: Behind RTK Signaling. Cells. 2019
- Euphol, a tetracyclic triterpene, from Euphorbia tirucalli induces autophagy and sensitizes temozolomide cytotoxicity on glioblastoma cells. Investigational New Drugs. 2019
- Euphol, a tetracyclic triterpene, from Euphorbia tirucalli induces autophagy and sensitizes temozolomide cytotoxicity on glioblastoma cells. Investigational New Drugs. 2019
- In vitro screening of cytotoxic activity of euphol from Euphorbia tirucalli on a large panel of human cancer-derived cell lines.. Experimental and Therapeutic Medicine. 2018
- Monocarboxylate transporter 1 is a key player in glioma-endothelial cell crosstalk. Molecular Carcinogenesis. 2017
- Serotonin regulates prostate growth through androgen receptor modulation. Acta Cytologica. 2017
- Metabolic alterations underlying Bevacizumab therapy in glioblastoma cells. Oncotarget. 2017
- AKT can modulate the in vitro response of HNSCC cells to irreversible EGFR inhibitors. Oncotarget. 2017
- Molecular characterization of short-term primary cultures and comparison with corresponding tumor tissue of Brazilian glioblastoma patients. Translational Cancer Research. 2017
- HER Family Receptors are Important Theranostic Biomarkers for Cervical Cancer: Blocking Glucose Metabolism Enhances the Therapeutic Effect of HER Inhibitors. Theranostics. 2017
- Hypoxia-mediated upregulation of MCT1 expression supports the glycolytic phenotype of glioblastomas. Oncotarget. 2016
- Molecular profiling, including TERT promoter mutations, of acral lentiginous melanomas. Melanoma Research. 2016
- Cytotoxicity of allitinib, an irreversible anti-EGFR agent, in a large panel of human cancer-derived cell lines: KRAS mutation status as a predictive biomarker. Cellular Oncology. 2016
- Raf Kinase Inhibitor Protein Expression and Prognostic Value in Soft Tissue Sarcomas. Pathobiology. 2016
- Raf Kinase Inhibitor Protein Expression and Prognostic Value in Soft Tissue Sarcomas. Pathobiology. 2016
- Glucose Addiction in Cancer Therapy: Advances and Drawbacks.. Current Drug Metabolism. 2015
- AXL as a modulator of sunitinib response in glioblastoma cell lines. Experimental Cell Research. 2015
- Silencing of the tumor suppressor gene WNK2 is associated with upregulation of MMP2 and JNK in gliomas. Oncotarget. 2015
- In vitro and in vivo studies of temozolomide loading in zeolite structures as drug delivery systems for glioblastoma. Nanoscale. 2015
- In vitro and in vivo studies of temozolomide loading in zeolite structures as drug delivery systems for glioblastoma. Nanoscale. 2015
- Silencing of WNK2 is associated with upregulation of MMP2 and JNK in gliomas. Oncotarget. 2015
- Analysis of a synchronous gliosarcoma and meningioma with long survival : a case report and review of the literature. Surgical Neurology International. 2013
- In Vitro and In Vivo Analysis of RTK Inhibitor Efficacy and Identification of Its Novel Targets in Glioblastomas. Translational Oncology. 2013
- RKIP Inhibition in Cervical Cancer Is Associated with Higher Tumor Aggressive Behavior and Resistance to Cisplatin Therapy. Antibiotics. 2013
- Low RKIP expression associates with poor prognosis in bladder cancer patients. Virchows Archiv. 2013
- Absence of RKIP expression is an independent prognostic biomarker for gastric cancer patients. Oncology Reports. 2013
- Loss of WNK2 expression by promoter gene methylation occurs in adult gliomas and triggers Rac1-mediated tumour cell invasiveness. Human Molecular Genetics. 2013
- Monocarboxylate transporters (MCTs) in gliomas: expression and exploitation as therapeutic targets. Neuro-Oncology. 2013
- Zeolite Structures Loading with an Anticancer Compound As Drug Delivery Systems. Journal of Physical Chemistry C. 2012
- Involvement of signaling molecules in the prediction of response to imatinib treatment in metastatic GIST patients. Journal of Surgical Research. 2012
- Co-expression of monocarboxylate transporter 1 (MCT1) and its chaperone (CD147) is associated with low survival in patients with gastrointestinal stromal tumors (GISTs). Journal of Bioenergetics and Biomembranes. 2012
- Co-expression of monocarboxylate transporter 1 (MCT1) and its chaperone (CD147) is associated with low survival in patients with gastrointestinal stromal tumors (GISTs). Journal of Bioenergetics and Biomembranes. 2012
- Downregulation of RKIP Is Associated with Poor Outcome and Malignant Progression in Gliomas. Antibiotics. 2012
- Downregulation of RKIP Is Associated with Poor Outcome and Malignant Progression in Gliomas. Antibiotics. 2012
- Loss of RKIP expression during the carcinogenic evolution of endometrial cancer. Journal of Clinical Pathology. 2012
- Loss of RKIP expression during the carcinogenic evolution of endometrial cancer. Journal of Clinical Pathology. 2012
- Encapsulation of a-cyano-4-hydroxycinnamic acid into a NaY zeolite. Journal of Materials Science. 2011
- Lymphangiogenic VEGF-C and VEGFR-3 expression in genetically characterised gastrointestinal stromal tumours. Histology and Histopathology. 2011
- Prognostic value of MGMT promoter methylation in glioblastoma patients treated with temozolomide-based chemoradiation: A Portuguese multicentre study. Oncology Reports. 2010
- A Canadian paediatric brain tumour consortium (CPBTC) phase II molecularly targeted study of imatinib in recurrent and refractory paediatric central nervous system tumours. Eur J Cancer. 2009
- Expression, mutation and copy number analysis of platelet-derived growth factor receptor A (PDGFRA) and its ligand PDGFA in gliomas. British Journal of Cancer. 2009
- Loss of RKIP expression is associated with poor survival in GISTs. Virchows Archiv. 2009
- Loss of RKIP expression is associated with poor survival in GISTs. Virchows Archiv. 2009
- Low frequency of MAP kinase pathway alterations in KIT and PDGFRA wild-type GISTs. Histopathology. 2009
- Low frequency of MAP kinase pathway alterations in KIT and PDGFRA wild-type GISTs. Histopathology. 2009
- Molecular characterization of EGFR, PDGFRA and VEGFR2 in cervical adenosquamous carcinoma. BMC Cancer. 2009
- Molecular characterization of EGFR, PDGFRA and VEGFR2 in cervical adenosquamous carcinoma. BMC Cancer. 2009
- KIT activation in uterine cervix adenosquamous carcinomas by KIT / SCF autocrine/paracrine stimulation loops. Gynecologic Oncology. 2008
- KIT activation in uterine cervix adenosquamous carcinomas by KIT / SCF autocrine/paracrine stimulation loops. Gynecologic Oncology. 2008
- Molecular alterations of KIT oncogene in gliomas. Cellular Oncology. 2007
-
capítulo de livro
- Chapter 20 - Implications of RKIP protein in cancer prognosis and therapy response: A literature update 2020
- Angiogenesis and Chromene-based Antiangiogenic Therapeutic Agents 2020
- Implications of RKIP protein in cancer prognosis and therapy response: A literature update 2020
- Angiogenesis and chromene-based antiangiogenic therapeutic agents 2019
- Bevacizumab for Glioblastoma Treatment: Reviewing Biological and Clinical Hypothesis for its Success and Failures 2016
- Malignant Gliomas: Role of Platelet-Derived Growth Factor Receptor A (PDGFRA) 2011
-
documento
- Beyond the MAPK Pathway: Unravelling the Importance of RKIP in Lung Adenocarcinoma 2023
- An in silico approach to identify Brachyury target genes in prostate cancer 2022
- An in silico approach to prostate cancer biomarkers 2022
- Embryonic T-box transcription factor Brachyury in androgen-dependent prostate cancer model 2022
- Embryonic T-box transcription factor Brachyury in androgen-dependent prostate cancer models 2022
- RKIP protein as a theranostic marker in HPV-related cancers. 2022
- The implication of RKIP loss in primary resistance to EGFR inhibitors in NSCLC: a novel predictive biomarker? 2022
- SENTINEL: "Novel injectable biosensor remote monitoring of cancer patients at high-risk of relapse" 2021
- Untangling the role of RKIP in NSCLC aggressiveness: an in vitro /in vivo and in silico analysis 2021
- Exploring the predictive andtherapeutic value of the embryonic T-box transcription factor Brachyury inlung cancer 2021
- Exploring the predictive and therapeutic value of the embryonic T-box transcription factor Brachyury in lung cancer 2021
- RKIP protein as a potential prognostic, aggressiveness and therapy response biomarker in HPV-related cancers 2021
- Role of RKIP protein in the modulation of lung cancer cell metabolism 2021
- Untangling the role of RKIP in NSCLC aggressiveness – an in vitro/vivo and in silico analysis 2021
- A proteína RKIP como um novo preditor de resposta a terapias anti-EGFR em cancro do pulmão 2021
- Compreender a regulação e sinalização da RKIP no cancro do colo do útero: RKIP/HER loop 2021
- Fator de transcrição embrionário T-boxBrachyury como biomarcador de resposta e alvo terapêutico em cancro do pulmão 2021
- Exploring the predictive andtherapeutic value of the embryonic T-box transcription factor Brachyury in lung cancer 2021
- A proteína RKIP como um novo preditor de resposta a terapias anti-EGFR em cancro do pulmão. 2021
- Compreender a regulação e sinalização da RKIP em cancro do colo do útero: RKIP/HER loop 2021
- Embryonic T-box transcription factor Brachyury as a predictive biomarker and therapeutic target in lung cancer 2021
- Fator de transcrição embrionário T-box Brachyury como biomarcador de resposta e alvo terapêutico em cancro do pulmão 2021
- RKIP protein as a novel predictor of EGFR targeted therapies in lung cancer 2021
- Embryonic T-box transcription factor Brachyury as a predictive biomarker andtherapeutic target in lung cancer 2021
- Role of RKIP protein in the modulation of cancer cells metabolism in solid tumors 2019
- RKIP protein as a potential prognostic, aggressiveness and therapy response biomarker in HNSCC 2019
- RKIP protein as a novel predictor of EGFR targeted therapies in lung cancer 2019
- RKIP protein induces HER receptors activation and positively modulate its pharmacological targeting in cervical cancer 2019
- RKIP protein as a novel predictor of EGFR targeted therapies in lung cancer 2018
- RKIP protein induces HER receptors activation and positively modulate its pharmacological targeting in cervical cancer 2018
- RKIP protein induces HER receptors activation and positively modulate its pharmacological targeting in cervical cancer. 2018
- The biological role of RKIP in head and neck cancer: an in vivo and in vitro study 2018
- RKIP protein as a novel predictor of EGFR targeted therapies in Lung Cancer. 2018
- Understanding the cellular metabolic reprogramming associated with bevacizumab therapy in glioblastoma 2017
- Blocking glucose metabolism enhances the effect of HER inhibitors in cervical cancer therapy 2016
- Blocking glucose metabolism enhances the effect of HER inhibitors in cervical cancer therapy. 2016
- HER receptors are important theranostic biomarkers on cervical cancer: blocking glucose metabolism enhances the therapeutic effect of HER inhibitors 2016
- HER receptors are important theranostic biomarkers on cervical cancer: blocking glucose metabolism enhances the therapeutic effect of HER inhibitors. 2016
- Funtional role and clinical impact of KIT GNNK+ and GNNK- isoforms in Glioblastoma. 2015
- Molecular characterization of an aggressive primary culture of Glioblastoma. 2015
- Role of AKT pathway in the predictive response of Allitinib, a new generation EGFR-inhibitor, in a panel of HNSCC cell lines. 2015
- The semi-synthetic ingenol C derived from Euphorbia tirucalli induces cell death via autophagy but not apoptosis in human glioma cancer cells. 2013
- WNK2 as a modulator of MMP-2 and MMP-9 expression and activity in Gliomas. 2013
- Testing a Novel Irreversible Anti-EGFR Drug for Head and Neck Cancer Treatment. 2013
- RKIP downregulation associates with poor prognosis in bladder cancer patients 2013
- RKIP downregulation associates with poor prognosis in bladder cancer patients 2012
- ASPM is an oncoprotein and activates EGFR 2010
- Analysis of MAP kinase signalling pathway in KIT & PDGFRA wild-type GISTs. 2008
- Analysis of the mitotic checkpoint competence in glioblastoma cell lines. 2008
- Correlation between the interferon (IFN) regulated protein GBP-2 and TP53 mutations in squamous cell carcinoma of the esophagus (SCCE). 2007
- Molecular characterization of KIT gene in cervix adenosquamous carcinomas. 2007
- Liquid based cytology in molecular research: viability and potential applications. 2007
- Genomic and transcriptomic profile of glioblastomas with KIT gene amplification. 2007
- Study of KIT Oncogene in Medulloblastomas 2007
- Evaluation of mitotic checkpoint integrity in glioblastoma cell lines. 2006
- Analysis of TP53 mutations in Diffuse Astrocytomas. 2006
-
teses